On 1 August 2023, the EU Commission published implementing Regulation (EU) 2023/1581 amending Implementing Regulation (EU) 2017/2470 as regards the conditions of use of the novel food ‘astaxanthin-rich oleoresin from Haematococcus pluvialis algae’. The new Regulation extends the conditions of use in food supplements for children aged 3 to less than 10 years and for adolescents aged 10 to less than 14 years of age (1).
The cannabidiol, CBD, an active substance most often of natural origin, is one of the phyto-cannabinoids. CBD, as the tétrahydrocannabinol (THC ), is present in the cannabis flowers and leaves. It is a non-addictive psychotropic drug, unlike THC. It is also a component in the form of an extract, medicine, or everyday consumer products, only some of which are authorised in France under specific conditions of THC content. In addition, CBD is considered at European level as a novel food whose safety is currently being assessed by EFSA.
The publication of a statutory instrument finally allows certain edible insects to be legally placed on the British market.
Under a new Regulation, lesser mealworm larvae enter the list of authorized novel foods.
Alphitobius diaperinus larvae may soon be on our plates!
On 28 June 2022, a webinar information session was held to present the recently published EFSA “Statement on safety of cannabidiol as a novel food: data gaps and uncertainties” to stakeholders.
The conditions of use of the ingredient are now set by Regulation (EU) 2022/860.
The conference was held on April 26th and 27th, and hosted a series of high caliber speakers
Over the course of 2021, the EU authorized a number of edible insects as Novel Foods. What is the post-Brexit situation in the UK?
Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the safety of Schizochytrium sp. oil as a Novel Food (NF) pursuant to Regulation (EU) 2015/2283.
Français